FdaApplication
ANDA 076996
Identifiers
- fda_app_no: ANDA076996
Properties
| Property | Value |
|---|---|
| applicant_name | ACTAVIS LABORATORIES FL INC |
| application_type | ANDA |
| approval_date | 2011-04-19 |
Products (5)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RISPERIDONE | RISPERIDONE | 4MG | TABLET, ORALLY DISINTEGRATING;ORAL |
| RISPERIDONE | RISPERIDONE | 1MG | TABLET, ORALLY DISINTEGRATING;ORAL |
| RISPERIDONE | RISPERIDONE | 0.5MG | TABLET, ORALLY DISINTEGRATING;ORAL |
| RISPERIDONE | RISPERIDONE | 2MG | TABLET, ORALLY DISINTEGRATING;ORAL |
| RISPERIDONE | RISPERIDONE | 3MG | TABLET, ORALLY DISINTEGRATING;ORAL |
5 products